Loading...
Date of Award
Spring 2025
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Jacinta Hollinger MMS, PA-C
Abstract
Hidradenitis Suppurativa (HS) is an autoinflammatory condition that causes debilitating, painful dermal lumps deep within the skin. This condition is frequently misdiagnosed, and can have severe complications, such as emergency room visits for sepsis or drainage for relief. Often, without proper management of this condition, it can lead to a decrease in quality of life and pain. Getting treatment can help reduce flare-ups; however, not every treatment option works for everyone or is safe for long-term use. Therefore, it is critical to stay updated on new clinical pharmacological treatment research/evidence that can help patients’ well-being. This article aims to provide evidence-based practice guidelines for treatment of HS. It aims to educate both healthcare providers and patients on the classification system for diagnosis, the potential causes, and misconceptions associated with the condition as well as treatment options for those suffering from HS.
Recommended Citation
Segal, Samantha N., "Breaking the Silence: Understanding Hidradenitis Suppurativa: Evidence-Based Approaches to Diagnosis and Treatment" (2025). Capstone Showcase. 14.
https://scholarworks.arcadia.edu/showcase/2025/pa/14
Breaking the Silence: Understanding Hidradenitis Suppurativa: Evidence-Based Approaches to Diagnosis and Treatment
Hidradenitis Suppurativa (HS) is an autoinflammatory condition that causes debilitating, painful dermal lumps deep within the skin. This condition is frequently misdiagnosed, and can have severe complications, such as emergency room visits for sepsis or drainage for relief. Often, without proper management of this condition, it can lead to a decrease in quality of life and pain. Getting treatment can help reduce flare-ups; however, not every treatment option works for everyone or is safe for long-term use. Therefore, it is critical to stay updated on new clinical pharmacological treatment research/evidence that can help patients’ well-being. This article aims to provide evidence-based practice guidelines for treatment of HS. It aims to educate both healthcare providers and patients on the classification system for diagnosis, the potential causes, and misconceptions associated with the condition as well as treatment options for those suffering from HS.